Deutsche Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,225,891
| Closed | -$15.2M | – | 5318 |
|
|
2016
Q4 | $15.2M | Sell |
1,225,891
-168,186
| -12% | -$2.03M | 0.01% | 1011 |
|
|
2016
Q3 | $19.1M | Buy |
1,394,077
+428,123
| +44% | +$4.3M | 0.01% | 944 |
|
|
2016
Q2 | $7.13M | Buy |
965,954
+173,118
| +22% | +$1.3M | 0.01% | 1516 |
|
|
2016
Q1 | $5.06M | Buy |
792,836
+523,830
| +195% | +$2.94M | ﹤0.01% | 1721 |
|
|
2015
Q4 | $1.68M | Buy |
269,006
+38,189
| +17% | +$251K | ﹤0.01% | 2558 |
|
|
2015
Q3 | $1.35M | Sell |
230,817
-496,216
| -68% | -$3.82M | ﹤0.01% | 2751 |
|
|
2015
Q2 | $6.01M | Sell |
727,033
-421,717
| -37% | -$3.73M | ﹤0.01% | 1680 |
|
|
2015
Q1 | $9.46M | Buy |
1,148,750
+997,802
| +661% | +$7.38M | 0.01% | 1378 |
|
|
2014
Q4 | $1.03M | Buy |
150,948
+7,299
| +5% | +$45.7K | ﹤0.01% | 3185 |
|
|
2014
Q3 | $774K | Sell |
143,649
-915,091
| -86% | -$5.34M | ﹤0.01% | 3198 |
|
|
2014
Q2 | $6.74M | Sell |
1,058,740
-229,665
| -18% | -$1.58M | ﹤0.01% | 1613 |
|
|
2014
Q1 | $10.4M | Buy |
1,288,405
+992,407
| +335% | +$7.73M | 0.01% | 1322 |
|
|
2013
Q4 | $2.02M | Sell |
295,998
-1,510,337
| -84% | -$8.15M | ﹤0.01% | 2290 |
|
|
2013
Q3 | $33.2M | Buy |
1,806,335
+617,268
| +52% | +$12M | 0.02% | 648 |
|
|
2013
Q2 | $20.8M | Buy |
+1,189,067
| New | +$21.1M | 0.02% | 857 |
|
Other funds holding ARIA
Deutsche Bank's ARIA Position: Q1 2017 in Review
Deutsche Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,225,891 shares — an estimated $15.2M sold.
Deutsche Bank first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $33.2M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Deutsche Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Deutsche Bank sold 1,225,891 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $15.2M.
- Deutsche Bank first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- Deutsche Bank's Ariad Pharmaceuticals Inc position peaked at $33.2M in Q3 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Deutsche Bank's 13F filing for Q1 2017, filed 15 May 2017.